The Board of Directors of Clinomics Inc. has authorized a buyback plan on August 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,520 KRW | -1.68% |
|
-2.56% | -40.74% |
05-17 | Clinomics Inc. announced that it has received KRW 4 billion in funding | CI |
05-14 | Clinomics Inc. announced that it expects to receive KRW 4 billion in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-40.74% | 42.85M | |
+16.59% | 44.44B | |
+41.02% | 40.03B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.29B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- A352770 Stock
- News Clinomics Inc.
- Clinomics Inc. authorizes a Buyback Plan.